KRAS Inhibitor Shrinks Tumors in Over 40% of NSCLC Patients
CHICAGO — More than 40% of patients with KRAS G12C-mutated non-small cell lung cancer (NSCLC) responded to treatment with adagrasib, findings from a phase II trial showed. Among 112 evaluable patients in the KRYSTAL-1 study, all of whom were previously treated, the confirmed objective response rate (ORR) was 42.9% with the investigational KRAS G12C inhibitor, […]
Increased Public Assistance Tied to Better Cancer Survival in Black Patients
CHICAGO — Overall survival (OS) in Black patients with cancer improved significantly, and racial disparities in cancer survival decreased, with increased state-level spending on public welfare programs, a large retrospective review showed. Every 10% increase in public welfare spending was associated with an 8.6% improvement in cancer survival among Black patients, almost four times greater […]
Research reveals new evidence that sugary beverage tax impacts are sustainable, effective: Tax in Seattle shows long-term reduction in demand and added sugars sold
Two new studies published by researchers at the University of Illinois Chicago provide evidence that public policies to reduce consumption of added sugars through taxes on sugar-sweetened beverages are effective and sustainable. Sugar-sweetened beverages like soda, juice, and energy and sports drinks, are the largest contributor of added sugars in American diets. Overconsumption of added […]
AMA Calls for Greater Police Accountability in New Report
CHICAGO — The American Medical Association (AMA) adopted new policies calling for greater police accountability and increased community involvement in policing practices, during its House of Delegates special meeting on Tuesday. “The AMA is strongly invested in the betterment of public health and remains committed to advocating for actionable reform to eliminate excessive police violence […]
AMA Delegates Spar Over Medicaid Coverage for Undocumented Pregnant Women
CHICAGO — Medicaid coverage for undocumented pregnant women, as well as those up to 12 months’ postpartum, garnered intense debate at a Sunday reference committee hearing during the virtual American Medical Association (AMA) special meeting of its House of Delegates. The debate came during a discussion of a resolution from the Medical Student Section asking […]
Mixed Results With RT Plus Short-Term ADT in Intermediate-Risk Prostate Cancer
CHICAGO — Adding a short course of androgen deprivation therapy (ADT) to dose-escalated radiotherapy (RT) led to a mixed bag of outcomes in intermediate-risk prostate cancer, according to a large randomized trial. The addition of 6 months of ADT did not improve overall survival (OS) compared with RT alone, but the hormonal therapy was associated […]
Meta-Analysis Reaffirms Role of ADT With Radiotherapy in Prostate Cancer
CHICAGO — The use of androgen deprivation therapy (ADT) in conjunction with radiotherapy, as well as its prolonged use in the adjuvant setting, improved metastasis-free survival (MFS) and overall survival (OS) in patients with localized prostate cancer, a meta-analysis found. Adding ADT to radiotherapy significantly improved 12-year rates of MFS, the primary endpoint (HR 0.83, […]